These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 29843539)
1. Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors. Peng J; Li Y; Zhou Y; Zhang L; Liu X; Zuo Z J Recept Signal Transduct Res; 2018 Jun; 38(3):246-255. PubMed ID: 29843539 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout: Molecular mechanisms and perspective. Ullah Z; Yue P; Mao G; Zhang M; Liu P; Wu X; Zhao T; Yang L Int J Biol Macromol; 2024 Oct; 278(Pt 3):134832. PubMed ID: 39168219 [TBL] [Abstract][Full Text] [Related]
3. Exploration of Novel Xanthine Oxidase Inhibitors Based on 1,6-Dihydropyrimidine-5-Carboxylic Acids by an Integrated in Silico Study. Zhai N; Wang C; Wu F; Xiong L; Luo X; Ju X; Liu G Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360886 [TBL] [Abstract][Full Text] [Related]
4. In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme. Malik N; Dhiman P; Khatkar A Curr Drug Metab; 2017; 18(6):577-593. PubMed ID: 28302027 [TBL] [Abstract][Full Text] [Related]
5. Study on the interaction mechanism between luteoloside and xanthine oxidase by multi-spectroscopic and molecular docking methods. Chen J; Wang Y; Pan X; Cheng Y; Liu J; Cao X J Mol Recognit; 2022 Dec; 35(12):e2985. PubMed ID: 35907782 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Xanthine Oxidase Inhibitors. Sun ZG; Wu KX; Ullah I; Zhu HL Mini Rev Med Chem; 2024; 24(12):1177-1186. PubMed ID: 37711003 [TBL] [Abstract][Full Text] [Related]
7. Cleroda-4(18),13-dien-15,16-olide as novel xanthine oxidase inhibitors: An integrated in silico and in vitro study. Nguyen HT; Vu TY; Dakal TC; Dhabhai B; Nguyen XHQ; Tatipamula VB PLoS One; 2021; 16(6):e0253572. PubMed ID: 34191831 [TBL] [Abstract][Full Text] [Related]
8. In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors. Malik N; Dhiman P; Khatkar A Curr Top Med Chem; 2019; 19(2):123-138. PubMed ID: 30727896 [TBL] [Abstract][Full Text] [Related]
9. Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation. Yan J; Zhang G; Hu Y; Ma Y Food Chem; 2013 Dec; 141(4):3766-73. PubMed ID: 23993547 [TBL] [Abstract][Full Text] [Related]
10. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones. Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174 [TBL] [Abstract][Full Text] [Related]
11. Various machine learning approaches coupled with molecule simulation in the screening of natural compounds with xanthine oxidase inhibitory activity. Zhou Q; Yin JY; Liang WY; Chen DM; Yuan Q; Feng BL; Zhang YH; Wang YT Food Funct; 2021 Mar; 12(4):1580-1589. PubMed ID: 33470259 [TBL] [Abstract][Full Text] [Related]
12. Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment. Li Y; Frenz CM; Li Z; Chen M; Wang Y; Li F; Luo C; Sun J; bohlin L; Li Z; Yang H; Wang C Chem Biol Drug Des; 2013 Apr; 81(4):537-44. PubMed ID: 23534413 [TBL] [Abstract][Full Text] [Related]
13. An in-depth view of potential dual effect of thymol in inhibiting xanthine oxidase activity: Electrochemical measurements in combination with four way PARAFAC analysis and molecular docking insights. Abbasi S; Gharaghani S; Benvidi A; Rezaeinasab M; Saboury AA Int J Biol Macromol; 2018 Nov; 119():1298-1310. PubMed ID: 30096398 [TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase inhibitory activity of natural and hemisynthetic flavonoids from Gardenia oudiepe (Rubiaceae) in vitro and molecular docking studies. Santi MD; Paulino Zunini M; Vera B; Bouzidi C; Dumontet V; Abin-Carriquiry A; Grougnet R; Ortega MG Eur J Med Chem; 2018 Jan; 143():577-582. PubMed ID: 29207340 [TBL] [Abstract][Full Text] [Related]
15. Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease? Orhan IE; Deniz FSS Curr Pharm Des; 2021; 27(2):143-158. PubMed ID: 32723252 [TBL] [Abstract][Full Text] [Related]
17. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related]
18. Novel insights into the inhibitory mechanism of kaempferol on xanthine oxidase. Wang Y; Zhang G; Pan J; Gong D J Agric Food Chem; 2015 Jan; 63(2):526-34. PubMed ID: 25539132 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia. Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421 [TBL] [Abstract][Full Text] [Related]
20. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors. Malik N; Khatkar A; Dhiman P Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]